We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$335M
Cap. Flow %
-50.06%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.26M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 7.59%
2 Technology 1.45%
3 Financials 0.54%
4 Consumer Discretionary 0.53%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$100M 14.93%
2,214
+987
+80% +$439K
DJT icon
2
PUT
Trump Media & Technology Group
DJT
$2.74B
$66.5M 9.93%
10,311
+9,333
+954% +$702K
OEF icon
3
CALL
iShares S&P 100 ETF
OEF
$19.8B
$63.1M 9.43%
3,076
+2,548
+483% +$523K
OEF icon
4
PUT
iShares S&P 100 ETF
OEF
$19.8B
$56.2M 8.4%
2,740
+703
+35% +$144K
DJT icon
5
CALL
Trump Media & Technology Group
DJT
$2.74B
$34.3M 5.12%
+5,312
New +$400K
VRPX
6
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$18.3M 2.74%
4,021
+514
+15% +$300K
VXX icon
7
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$10.8M 1.61%
262
-174
-40% -$64.1K
BCTXW
8
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$6.61M 0.99%
6,519
+2,218
+52% +$8.83K
PSTH
9
CALL
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$3.99M 0.6%
+2,007
New +$39.8K
COCP icon
10
Cocrystal Pharma
COCP
$12.9M
$3.09M 0.46%
467,670
-10,507
-2% -$69.9K
PMCB icon
11
PharmaCyte Biotech
PMCB
$6.33M
$2.93M 0.44%
1,275,468
+57,640
+5% +$128K
BIVI icon
12
BioVie
BIVI
$10M
$2.89M 0.43%
6,129
-353
-5% -$130K
AIOS
13
AIOS Tech
AIOS
$41.1M
$2.81M 0.42%
14,383
-1,751
-11% -$476K
REW icon
14
PUT
Proshares UltraShort Technology
REW
$3.65M
$2.75M 0.41%
121
-75
-38% -$9.71K
CNTX icon
15
Context Therapeutics
CNTX
$54.3M
$2.53M 0.38%
1,165,100
-65,730
-5% -$138K
AGMH icon
16
AGM Group Holdings
AGMH
$1.82M
$2.45M 0.37%
23,560
-6,309
-21% -$580K
HMCO
17
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$2.4M 0.36%
244,684
-159,501
-39% -$1.56M
CAN
18
PUT
Canaan Creative
CAN
$178M
$2.4M 0.36%
4,420
-6,242
-59% -$31.2K
NBEV
19
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$2.3M 0.34%
3,956,726
+1,561,573
+65% +$1.12M
OG
20
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$2.14M 0.32%
1,320,750
– –
NRXP icon
21
NRX Pharmaceuticals
NRXP
$152M
$1.92M 0.29%
+78,247
New +$2.55M
ZVRA icon
22
PUT
Zevra Therapeutics
ZVRA
$575M
$1.84M 0.27%
3,651
+785
+27% +$5K
RCON icon
23
Recon Technology
RCON
$39.6M
$1.82M 0.27%
93,431
-56,219
-38% -$1.11M
GLBS icon
24
Globus Maritime Ltd
GLBS
$60.9M
$1.65M 0.25%
714,163
-2,213
-0.3% -$4.61K
PULM icon
25
Pulmatrix
PULM
$6.14M
$1.63M 0.24%
237,958
+57,106
+32% +$415K
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $335M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.26M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.